News & Events
Hardman & Co analyst, Steve Clapham, discusses the rise of ‘Accounting Fraud’ at Mello London
This week Hardman & Co analyst, Steve Clapham, made a fantastic contribution to Mello London; a unique Investor conference offering access to 50+ high-quality growth companies, outstanding keynote investment industry speakers from whom to learn, and the opportunity to network with fellow private investors.
‘Disruption, Disruption, Disruption’: Hardman & Co analyst Nigel Hawkins presents at Mello London
Yesterday, Hardman & Co analyst Nigel Hawkins presented on the topic of market disruption to a full house at Mello London.
VIDEO: Paul Mylchreest on the fundamentals driving demand for Lithium
Our mining analyst, Paul Mylchreest updates London South East with the change in demand for Lithium, in part driven by the growth of electric vehicles.
MIFID II dampening liquidity and cutting research
Liquidity – a key measure of investors’ ability to buy and sell shares without significantly moving the price – has fallen 16% on the London Stock Exchange Main Market since MiFID II came into force, according to Hardman & Co analysis.
Financial Times features new Hardman & Co findings in the Lex column
Lex today feature new Hardman & Co findings which highlight both the receding liquidity in mid-cap AIM stocks and the reduction in research coverage.
Liquidity of mid-cap AIM stocks diminishing post MiFID II- Investment Week
Mike Sheen of Investment Week features Hardman & Co MiFID II Monitor data highlight drop in liquidity and research coverage.
Hardman & Co Quarterly Newsletter
It has been a busy year at Hardman & Co, we have welcomed new team members, new clients, and given our brand a makeover. 2018 has also been a landmark year for us, celebrating 21 years in business. The launch of our MiFID II Monitor We have launched the MiFIDII monitor, designed to track the […]
Tony Williams quoted in Investors Chronicle: ‘Bargain Shares: Repeating buying opportunities’
Titon named as one of the ten small-cap companies to make Simon Thompson’s 2018 Bargain Shares Portfolio.
Evening Standard feature Dr Martin Hall on the Advanced Oncotherapy investment story
‘Market Minnows: Cancer firm Advanced Oncotherapy might be a long-term winner’.
Twitter latest
- $VTA #VoltaFinance Interview with Mark Thomas published: 'Delivering a steady flow of interest from diverse portfol… https://t.co/SLnlsME9S3